Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Journey Medical (DERM) Return on Capital Employed (2021 - 2025)

Historic Return on Capital Employed for Journey Medical (DERM) over the last 5 years, with Q3 2025 value amounting to 0.13%.

  • Journey Medical's Return on Capital Employed rose 4500.0% to 0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13%, marking a year-over-year increase of 4500.0%. This contributed to the annual value of 0.32% for FY2024, which is 2700.0% down from last year.
  • Latest data reveals that Journey Medical reported Return on Capital Employed of 0.13% as of Q3 2025, which was up 4500.0% from 0.16% recorded in Q2 2025.
  • Over the past 5 years, Journey Medical's Return on Capital Employed peaked at 0.07% during Q2 2024, and registered a low of 2.51% during Q2 2023.
  • For the 5-year period, Journey Medical's Return on Capital Employed averaged around 0.59%, with its median value being 0.52% (2022).
  • Per our database at Business Quant, Journey Medical's Return on Capital Employed plummeted by -19900bps in 2023 and then skyrocketed by 25800bps in 2024.
  • Over the past 5 years, Journey Medical's Return on Capital Employed (Quarter) stood at 0.84% in 2021, then increased by 18bps to 0.69% in 2022, then soared by 90bps to 0.07% in 2023, then tumbled by -427bps to 0.37% in 2024, then skyrocketed by 66bps to 0.13% in 2025.
  • Its Return on Capital Employed was 0.13% in Q3 2025, compared to 0.16% in Q2 2025 and 0.16% in Q1 2025.